Skip to main navigation Skip to search Skip to main content

Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy: applying the MOGE(S) classification

  • Mark R. Hazebroek (Corresponding author)
  • , Suzanne Moors
  • , Robert Dennert
  • , Arthur van den Wijngaard
  • , Ingrid Krapels
  • , Marije Hoos
  • , Job Verdonschot
  • , Jort J. Merken
  • , Bart de Vries
  • , Petra F. Wolffs
  • , Harry J.G.M. Crijns
  • , Hans-Peter Brunner-La Rocca
  • , Stephane Heymans

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

BACKGROUND: The multifactorial pathogenesis leading to dilated cardiomyopathy (DCM) makes stratification difficult. The recent MOGE(S) (morphofunctional, organ involvement, genetic or familial, etiology, stage) classification addresses this issue.

OBJECTIVES: The purpose of this study was to investigate the applicability and prognostic relevance of the MOGE(S) classification in patients with DCM.

METHODS: This study used patients from the Maastricht Cardiomyopathy Registry in the Netherlands and excluded patients with ischemic, valvular, hypertensive, and congenital heart disease. All other patients underwent a complete diagnostic work-up, including genetic evaluation and endomyocardial biopsy.

RESULTS: A total of 213 consecutive patients with DCM were included: organ involvement was demonstrated in 35 (16%) and genetic or familial DCM in 70 (33%) patients, including 16 (8%) patients with a pathogenic mutation. At least 1 cause was found in 155 (73%) patients, of whom 48 (23%) had more than 1 possible cause. Left ventricular reverse remodeling was more common in patients with nongenetic or nonfamilial DCM than in patients with genetic or familial DCM (40% vs. 25%; p = 0.04). After a median follow-up of 47 months, organ involvement and higher New York Heart Association functional class were associated with adverse outcome (p < 0.001 and p = 0.02, respectively). Genetic or familial DCM per se was of no prognostic significance, but when it was accompanied by additional etiologic-environmental factors such as significant viral load, immune-mediated factors, rhythm disturbances, or toxic triggers, a worse outcome was revealed (p = 0.03). A higher presence of MOGE(S) attributes (≥2 vs. ≤1 attributes) showed an adverse outcome (p = 0.007).

CONCLUSIONS: The MOGE(S) classification in DCM is applicable, and each attribute or the gene-environment interaction is associated with outcome. Importantly, the presence of multiple attributes was a strong predictor of adverse outcome. Finally, adaptation of the MOGE(S) involving multiple possible etiologies is recommended.

Original languageEnglish
Pages (from-to)1313-23
Number of pages11
JournalJournal of the American College of Cardiology
Volume66
Issue number12
DOIs
Publication statusPublished - 22 Sept 2015
Externally publishedYes

Keywords

  • Adult
  • Cardiomyopathy, Dilated/classification
  • Female
  • Gene-Environment Interaction
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Severity of Illness Index

Fingerprint

Dive into the research topics of 'Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy: applying the MOGE(S) classification'. Together they form a unique fingerprint.

Cite this